Integrated Histomolecular Classification of Diffuse Gliomas

A tétel rövid nézete
dc.contributor.advisorSANDOR, SZABO
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Idegsebészeti Klinikahu_HU
dc.contributor.authorÖKSÜZ, ALİ
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentVirga, József
dc.contributor.opponentHutóczki, Gábor
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Onkológiai Intézethu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Idegsebészeti Klinikahu_HU
dc.date.accessioned2022-08-20T09:58:19Z
dc.date.available2022-08-20T09:58:19Z
dc.date.created2022-01-11
dc.description.abstractGliomas are most common primary brain tumor in the brain causing significant mortality and morbidity. 2016 WHO classification of gliomas is multi-layered sytem that involves molecular biomarkers, WHO grade and histology of gliomas to obtain final integrated diagnosis. We collected reports of total 404 operated patients in our clinic and compared prevelance, diagnosis and testing of molecular markers with current trends with change of 2016 CNS tumor classification by WHO.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent37hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336647
dc.language.isoenhu_HU
dc.subjectGlioblastomahu_HU
dc.subjectoligodendrogliomahu_HU
dc.subjectastrocytomahu_HU
dc.subjectWHO CNS Tumar classification 2016hu_HU
dc.subjectIdh-mutationhu_HU
dc.subject1p/19q codeletionhu_HU
dc.subjectTp53 mutationhu_HU
dc.subjectEGFR amplificationhu_HU
dc.subjectMGMThu_HU
dc.subjectpromoter methylationhu_HU
dc.subjectATRXhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleIntegrated Histomolecular Classification of Diffuse Gliomashu_HU
dc.title.subtitlea review and 1 year survey in Neurosurgical Department, University Debrecenhu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)